Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cGAS–STING–NF-κB signaling axis is a fundamental innate immune pathway in macrophages that detects double-stranded DNA (dsDNA) in the cytoplasm, which serves as a marker for infection or cellular damage (Nature Reviews Immunology, 2019, PMID: 30770883). The enzyme cyclic GMP-AMP synthase (cGAS) acts as the primary sensor, binding to dsDNA and catalyzing the synthesis of the second messenger cyclic GMP-AMP (cGAMP) (Science, 2013, PMID: 23258413). cGAMP then binds to the stimulator of interferon genes (STING) on the endoplasmic reticulum, triggering a conformational change that allows STING to recruit and activate the IκB kinase (IKK) complex (Cell, 2013, PMID: 23722159). This activation leads to the phosphorylation and degradation of IκB, permitting the transcription factor NF-κB to translocate into the nucleus and initiate the expression of pro-inflammatory cytokines and type I interferons (Nature Communications, 2017, PMID: 28931823). While this axis is vital for defense against pathogens, its chronic activation is a driver of autoimmune diseases such as Aicardi-Goutières syndrome and systemic lupus erythematosus, making it a target for inhibitory drugs (Nature, 2014, PMID: 24948750). Conversely, STING agonists are being developed as cancer immunotherapies to turn “cold” tumors “hot” by stimulating macrophage-mediated inflammatory responses within the tumor microenvironment (Journal of Hematology & Oncology, 2020, PMID: 32819424).
Activation of cGAS by cytosolic DNA leads to the production of cGAMP, which binds and activates STING; activated STING then recruits the IKK complex to trigger NF-κB nuclear translocation and the subsequent transcription of pro-inflammatory genes.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclic GMP-AMP synthase–Stimulator of interferon genes–Nuclear factor kappa-light-chain-enhancer of activated B cells signaling axis (cGAS–STING–NF-κB axis) (cGAS–STING–NF-κB axis).